For years, effective GLP-1 weight loss treatment meant needles. That changed in April 2026, when the FDA approved orforglipron (brand name Foundayo), the first oral, once-daily GLP-1 medication for chronic weight management that doesn't come with a syringe, a refrigerator requirement, or food and water timing restrictions. As an Internal Medicine physician, I've already had a wave of patients ask whether the "GLP-1 pill" is the easier option they've been waiting for. Here's w

Peptide therapy is everywhere in 2026 — from GLP-1 shots to BPC-157 vials sold online. Here's what an Internal Medicine physician wants you to know about which peptides are backed by real evidence and which are still a gamble.

The FDA is moving to permanently bar compounding pharmacies from making copies of semaglutide and tirzepatide. Here's what's driving the crackdown, the real safety risks behind it, and what to do if you're currently using a compounded GLP-1.

The ACC/AHA released a major 2026 cholesterol guideline update — lower LDL targets, universal Lp(a) testing, and a new risk calculator. Here's what it means for your next physical.

If your diet is clean, you're working out consistently, and the scale still won't move, you're not imagining it, and you're not failing. As an Internal Medicine physician, I regularly see patients doing everything "right" who still struggle to lose weight. In most cases, the problem isn't willpower. It's biology. Below are seven real, evidence-based medical reasons your body may be resisting weight loss, and what you can do about each one. Watch the full video: Why You're Sti